15.05.2014 Views

Business Investing in Malaria Control: Economic Returns and ... - Path

Business Investing in Malaria Control: Economic Returns and ... - Path

Business Investing in Malaria Control: Economic Returns and ... - Path

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ANNEX A. METHODS TO ASSESS THE<br />

BENEFITS OF PRIVATE-SECTOR CONTROL<br />

EFFORTS IN ZAMBIA<br />

This annex describes the methodology used to exam<strong>in</strong>e the health <strong>and</strong> economic benefits of<br />

the malaria control efforts made by three large Zambian companies.<br />

BUSINESS INVESTING IN MALARIA CONTROL: ECONOMIC RETURNS AND A HEALTHY WORKFORCE FOR AFRICA<br />

Extensive work was done with f<strong>in</strong>ancial managers<br />

<strong>and</strong> health staff <strong>in</strong> each of the three companies<br />

to compile the data from 2000–2009 required to<br />

conduct the analysis. The companies provided<br />

health services for their employees <strong>and</strong> family<br />

members <strong>and</strong> had ma<strong>in</strong>ta<strong>in</strong>ed good record keep<strong>in</strong>g<br />

of health events <strong>and</strong> of the costs of these events<br />

over that time period. The companies also had<br />

consistent records of production <strong>and</strong> per-employee<br />

production <strong>and</strong> costs <strong>and</strong> profits over this time.<br />

F<strong>in</strong>ally, the companies ma<strong>in</strong>ta<strong>in</strong>ed good records<br />

of their costs for malaria control work <strong>in</strong> staff<br />

homes <strong>and</strong> nearby communities. These records<br />

were reviewed by <strong>in</strong>dependent observers with<br />

the permission <strong>and</strong> support of the companies, <strong>and</strong><br />

summaries were developed for this report.<br />

The three steps mentioned <strong>in</strong> Chapter 3, lead<strong>in</strong>g<br />

to the determ<strong>in</strong>ation of the number of malaria<br />

episodes averted, the medical cost sav<strong>in</strong>gs <strong>and</strong> the<br />

absence sav<strong>in</strong>gs (Figure A.1; same as Figure 2.2) are<br />

described <strong>in</strong> detail <strong>in</strong> this annex. They are essential<br />

steps <strong>in</strong> the calculations needed to determ<strong>in</strong>e the<br />

actual net benefits of malaria control by the private<br />

companies.<br />

Figure A.1<br />

Data collection <strong>and</strong> analysis sequence to exam<strong>in</strong>e bus<strong>in</strong>ess <strong>in</strong>vestment <strong>in</strong> malaria control at Zambia<br />

Sugar, Mopani Copper M<strong>in</strong>es <strong>and</strong> Konkola Copper M<strong>in</strong>es, Zambia, 2001–2009<br />

Basel<strong>in</strong>e<br />

malaria<br />

<strong>in</strong>cidence<br />

<br />

Workforce<br />

Household<br />

size<br />

<br />

Average<br />

absences per<br />

episode<br />

<br />

Average<br />

daily pay<br />

<br />

<br />

<br />

Primary variables<br />

Actual malaria<br />

episodes<br />

<br />

Step I:<br />

<strong>Malaria</strong><br />

episodes<br />

averted<br />

Step II:<br />

Medical cost<br />

sav<strong>in</strong>gs<br />

<br />

Step III:<br />

Absence<br />

sav<strong>in</strong>gs<br />

<br />

<br />

<br />

Share of<br />

<strong>in</strong>- <strong>and</strong><br />

out-patients<br />

<br />

Average cost<br />

of <strong>in</strong>- <strong>and</strong><br />

out-patients<br />

Costs of<br />

malaria<br />

control<br />

Net benefits<br />

of malaria<br />

control<br />

Secondary variables (=calculated)<br />

<br />

46

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!